2011
DOI: 10.1007/s12262-011-0281-y
|View full text |Cite
|
Sign up to set email alerts
|

Multiple Metachronous Malignancies, One Patient with Three Primary Malignancies

Abstract: Development of a primary cancer after treatment of the first with radiotherapy or chemotherapy is well documented, but it is common with hematological malignancies. Variety of reasons are suggested by various researchers, but a conclusive evidence is not yet available. Excepting a few correlations like the tamoxifen therapy and endometrial cancer, angiosarcoma of the breast following radiotherapy, occurrence of other metachronous malignancies seem to be dependent on genetic and environmental factors. A patient… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…This may lead to the development of MPM at some point during the lifetime [ 19 22 ]. Multiple metachronous malignancies are frequently detected in hematological, lung, thyroid, breast, skin, and genitourinary malignancies [ 23 , 24 ]. Liu et al investigated the etiological factors, clinical characteristics, diagnosis, treatment strategies, and prognosis of MPM and demonstrated that curative surgery has a strong impact on long-term prognosis [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…This may lead to the development of MPM at some point during the lifetime [ 19 22 ]. Multiple metachronous malignancies are frequently detected in hematological, lung, thyroid, breast, skin, and genitourinary malignancies [ 23 , 24 ]. Liu et al investigated the etiological factors, clinical characteristics, diagnosis, treatment strategies, and prognosis of MPM and demonstrated that curative surgery has a strong impact on long-term prognosis [ 22 ].…”
Section: Discussionmentioning
confidence: 99%